Fifth Third Bancorp Amarin Corp Plcuk Transaction History

Fifth Third Bancorp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 19, 2022	SELL	$2.85 - $3.73 $9,547 - $12,495	-3,350 Closed	0 $0
Q1 2020 May 05, 2020	SELL	$4.0 - $21.53 $2,000 - $10,765	-500 Reduced 12.99%	3,350 $13,000
Q1 2019 May 14, 2019	SELL	$12.61 - $22.33 $1,891 - $3,349	-150 Reduced 3.75%	3,850 $80,000
Q4 2018 Feb 14, 2019	BUY	$12.41 - $22.98 $49,640 - $91,920	4,000 New	4,000 $54,000

177

69.9M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $246M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

Stay updated on Fifth Third Bancorp with notifications on news.